These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30041965)

  • 1. Failure of gastric prophylaxis against stress bleeding reflects inadequate pH control.
    Mesquita WJ; Kline CM; Vernier P; Ledgerwood AM; Lucas CE
    Surgery; 2018 Oct; 164(4):733-737. PubMed ID: 30041965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric pH control in critically ill children receiving intravenous ranitidine.
    Harrison AM; Lugo RA; Vernon DD
    Crit Care Med; 1998 Aug; 26(8):1433-6. PubMed ID: 9710105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?
    Patel AJ; Som R
    Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):356-60. PubMed ID: 23208652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-related mucosal disease: risk factors and prophylactic therapy.
    Spirt MJ
    Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
    Avendaño-Reyes JM; Jaramillo-Ramírez H
    Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine is unable to maintain gastric pH levels above 4 in septic patients.
    Terzi Coelho CB; Dragosavac D; Coelho Neto JS; Montes CG; Guerrazzi F; Andreollo NA
    J Crit Care; 2009 Dec; 24(4):627.e7-13. PubMed ID: 19931156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU.
    Krag M; Marker S; Perner A; Wetterslev J; Wise MP; Schefold JC; Keus F; Guttormsen AB; Bendel S; Borthwick M; Lange T; Rasmussen BS; Siegemund M; Bundgaard H; Elkmann T; Jensen JV; Nielsen RD; Liboriussen L; Bestle MH; Elkjær JM; Palmqvist DF; Bäcklund M; Laake JH; Bådstøløkken PM; Grönlund J; Breum O; Walli A; Winding R; Iversen S; Jarnvig IL; White JO; Brand B; Madsen MB; Quist L; Thornberg KJ; Møller A; Wiis J; Granholm A; Anthon CT; Meyhoff TS; Hjortrup PB; Aagaard SR; Andreasen JB; Sørensen CA; Haure P; Hauge J; Hollinger A; Scheuzger J; Tuchscherer D; Vuilliomenet T; Takala J; Jakob SM; Vang ML; Pælestik KB; Andersen KLD; van der Horst ICC; Dieperink W; Fjølner J; Kjer CKW; Sølling C; Sølling CG; Karttunen J; Morgan MPG; Sjøbø B; Engstrøm J; Agerholm-Larsen B; Møller MH;
    N Engl J Med; 2018 Dec; 379(23):2199-2208. PubMed ID: 30354950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of stress-related mucosal disease.
    Monnig AA; Prittie JE
    J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):484-95. PubMed ID: 22316196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of gastrointestinal bleeding due to stress ulceration: a review of current literature.
    Pilkington KB; Wagstaff MJ; Greenwood JE
    Anaesth Intensive Care; 2012 Mar; 40(2):253-9. PubMed ID: 22417019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM; Scates AC; Latour JK
    Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors].
    Tank S; Kerner T
    Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1338. PubMed ID: 24914510
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
    Cook D; Guyatt G
    N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
    Critchlow JF
    Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for pH control in upper gastrointestinal bleeding.
    Brunner G; Luna P; Thiesemann C
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
    Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
    Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.